Back to FDA Applications sponsored by VERTEX PHARMS

FDA Drug Application 201917 by VERTEX PHARMS

Application Number201917
Application Type New Drug Application
Sponsor ApplicantVERTEX PHARMS
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Priority
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP05/23/2011N28878000 5/23/2011
AP05/23/2011N28879000 5/23/2011
AP05/23/2011N28880000 5/23/2011
AP05/23/2011N28881000 5/23/2011
AP05/23/2011N29459000 7/8/2011
AP05/23/2011N29460000 7/8/2011
AP05/23/2011N34770000 12/27/2012
AP03/22/2012SLR32177003 3/23/2012
AP03/22/2012SLR32178003 3/23/2012
AP03/22/2012SLR32187003 3/26/2012
AP06/22/2012SLR32991004 6/25/2012
AP06/22/2012SLR33023004 6/26/2012
AP06/22/2012SLR33024004 6/26/2012
AP012/14/2012SLR34671007 12/17/2012
AP012/14/2012SLR34709007 12/19/2012
AP04/25/2013SLR35867008 4/29/2013
AP04/25/2013SLR35883008 4/30/2013
AP010/28/2013SE837601010 10/28/2013
AP010/28/2013SE837604010,s012ltr.pdf 10/29/2013
AP010/28/2013SLR37605012,s012ltr.pdf 10/29/2013
AP010/28/2013SLR37600012 10/28/2013

Back to FDA Applications sponsored by VERTEX PHARMS

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.